Emergencies 24 h

900 407 407

Oncology. Vithas Xanit Oncological Institute

General Information

Descripción larga: 

We are there for you when you most need us. Cancer treatment is generally a long 'fight' and so we wish to be by your side guaranteeing access and knowledge of the latest progress and offering you maximum psychological support and making your road to recovery as easy as possible.

At the Vithas Xanit Oncological Institute, we aim to always provide a high quality, scientific and human cancer diagnosis and treatment. This is a multi-disciplinary area where a patient is diagnosed, seen by the oncologist and can be operated on and treated within the week.

The hospital also has a Cancer Prevention Unit in order to considerably reduce the incidence and mortality of breast, colon-rectal, cervical and lung cancer and a Hereditary Cancer Unit to detect and advise the population who have a greater family risk. Prevention is often the best cure.

We also have a Tumour Committee that brings together all the professionals involved in the diagnosis and treatment of cancer. It meets periodically to analyse new cases as recommended by the National Cancer Strategy.


Brain Tumours
  • Radical treatment of malignant tumours with radiotherapy and radio-chemotherapy.
  • Complementary treatment of operated malignant tumours with radiotherapy and radio-chemotherapy.
  • Radiation on the cranial-spinal column.
  • Full treatment of brain metastasis.

Head and Neck Tumours
  • Non surgical treatment of tumours in initial stages by means of radical radiotherapy.
  • Conservative treatment of the organ and function of advanced stage tumours.
  • Radical treatment of inoperable advanced tumours.
  • Complementary radiotherapy and radio-chemotherapy in operated tumours.
  • Systemic and palliative radiotherapy treatment of returning or metastatic tumours.

Lung Tumours
  • Radical radiotherapy treatment of tumours in initial stages.
  • Pre-operatory and post-operatory chemotherapy for non microcytic lung cancer.
  • Concomitant radio-chemotherapy in non microcytic stage IIIB cancer.
  • Concomitant chemoradiotherapy in localised microcytic cancer.
  • Medical treatment for disseminated or returning lung cancer.
  • Prophylactic brain radiation in microcytic lung cancer.

Breast Tumours
  • Medical and radiotherapy treatment of operable breast cancer.
  • Medical and radiotherapy treatment of operable breast cancer.
  • Full treatment of non operable breast cancer (locally advanced).
  • Full treatment of disseminated breast cancer.

Digestive Tumours
  • Adjuvant chemotherapy treatment after surgery on colon, rectum and pancreas tumours.
  • Adjuvant treatment with chemotherapy and radiotherapy on stomach cancer.
  • Pre-operatory treatment on cancer of rectum.
  • Conservative treatment on sphincter in initial stages of cancer of rectum.
  • Non surgical treatment of anal canal cancer.
  • Concomitant treatment with chemotherapy and radiotherapy of cancer of the oesophagus.
  • Radio-chemotherapy treatment if locally advanced cancer of the pancreas.
  • Pre-operatory treatment of hepatic metastasis of colon cancer.
  • Full treatment of disseminated digestive cancer.
  • Treatment of gastrointestinal sarcomas.

Urological Tumours
  • Radiotherapy treatment of localised prostate cancer.
  • Adjuvant treatment of operable cancer of the bladder.
  • Systemic treatment of locally advanced and metastatic cancer of the bladder.
  • Systemic treatment of prostate cancer.
  • Systemic treatment of testicular cancer.

Gynaecological Tumours
  • Adjuvant chemotherapy treatment of operable ovarian cancer.
  • Full treatment of non resectable ovarian cancer.
  • Treatment of cervical cancer with radio-chemotherapy.
  • Complementary radiotherapy treatment for endometrial cancer.
  • Radiotherapy treatment of cancer of the vulva and vagina.
  • Systemic treatment of disseminated gynaecological cancer.

Bone and Soft Tissue Tumours
  • Neo-adjuvant and conservative treatment of limb in osteosarcoma.
  • Radiotherapy treatment on localised sarcomas (adjuvant or neoadjuvant).
  • Adjuvant chemotherapy treatment in operated soft tissue sarcomas.

Systemic Treatment of Disseminated Tumours

Hodgkin and Non-Hodgkin Lymphoma
  • Full treatment of both processes.

  • Post-operatory adjuvant treatment.
  • Medical treatment of the disseminated disease.

Palliative Treatments with Radiotherapy
  • Brain metastasis treatments.
  • Bone metastasis treatments.
  • Soft tissue metastasis treatments.

Benign Lesion Treatments with Radiotherapy
  • Hypophyseal adenomas.
  • Parotid adenomas.
  • Carcinoid tumours.
  • Chemodectomas, Paragangliomas.
  • Desmoid tumours.
  • Hyperthyroid Ophthalmic pathology.
  • Bone hemangiomas.
  • Heterotopic ossification.
  • Hypersplenism.

Genetic Advice Unit
  • Hereditary colon cancer.
  • Hereditary breast and ovarian cancer.

Treatment Methods

Radiotherapy Treatment
  • 3D virtual simulation for external radiotherapy and high rate dosage brachytherapy with RMN, TC with 64 cuts and scan.
  • 3D External radiotherapy made up of automatic positioning control and organ movement control.
  • Intensity-Modulated Radiation Therapy (IMRT).
  • Image Guided Radiotherapy (IGRT).
  • Conformed Dynamic Arc Therapy.
  • Radiosurgery with Frameless System.
  • Conformed sterotaxic radiotherapy inside and outside cranium.
  • High dosage rate intracavitary and interstitial brachytherapy with 3D planning in TC.
  • Prostatic brachytherapy with permanent I 125 implants.

Medical Treatment
  • Intravenous and oral chemotherapy for solid tumours and lymphomas.
  • Hormone therapy for breast and prostate cancer.
  • Monoclonal antibodies intravenously for treatment of solid tumours and lymphomas.
  • Guided drugs against new molecular targets orally and intravenously.
  • Radioimmunotherapy on non Hodgkin's lymphoma.
  • Immunotherapy: interleukin and interferon.

VARIAN CLINAC 2100 CD multi-energy high energy linear electron accelerator with:
  • Photons: 6 and 18 MV.
  • Electrons: 6,9,12,16 and 20 MeV.
  • Dynamic cradles.
  • Micro-multileaf for total field MLC 120.
  • Guard Collision Laser.
  • Automatic field sequencing (AFS).
  • Dynamic MLC (Sliding Windows IMRT).
  • Amorphous Silicon Vision Portal.

Image Guided Radiotherapy (IGRT).
  • Image and dosimetric control system with amorphous silicon sensors.
  • Image system to control "On Board Imaging" OBI positioning.
  • "Cone-Beam" system to control movement of organs being treated.

  • "Frameless" system, non invasive radiosurgery method.
  • "RadioCameras Treatment Guidance System".

High rate Ir 192 VARISOURCE 200 brachytherapy with 20 channels

Prostatic brachytherapy with permanent I 125 implant
  • RAPID Strand seeds.

3D Planning Systems
  • Eclipse.
  • IMRT: Helios.
  • HDR: Brachyvision.
  • Radiosurgery: Fastplan and InMerge System.
  • Permanent implant Prostatic Brachytherapy PCRT 3D.

VARIS/Vision NETWORK version 7: integrated computer management system.


  • Dr. Carabantes, Francisco
  • Dra. Nuño, Cristina
  • Dra. Quero, Cristina
  • Dra. Ríos, María Belén
  • Dr. Sánchez, Pedro
  • Dr. Trujillo, Rafael


Preguntas frecuentes: 

What are the causes of cancer?

Cancer develops when genetic mutations occur in a group of cells. It is a process in which the risk factors like diet, obesity, life style and infections influence its appearance. As such, not all cancers develop for the same reasons; lung cancer, for example, is related with smoking and skin cancer with excess sun.

Is cancer hereditary?

The majority of cancers are from non-hereditary causes; only 5-15% of all cancers are hereditary in origin. When we speak about hereditary cancer we must take into account that what is inherited is not the illness but rather the genetic predisposition. Among the most frequent are breast cancer and colorectal cancer related with 15% and 10% respectively.

Can cancer be prevented?

Some tumours can be prevented, meaning, reduce the probability that they may appear by changing certain life habits such as the relationship between smoking and lung cancer, etc. In cervix, colon and lung cancer there are certain tests that can be done on populations with very specific characteristics, which have demonstrated real effectiveness in the early diagnosis of the tumours. Thanks to this possibility to diagnose cancer at such an initial stage, the probability of a cure with the appropriate treatment is very high.

How is cancer treated?

The three weapons are surgery, radiotherapy and medical treatment (chemotherapy, hormone therapy and new anti-target pharmaceuticals). While the radiotherapy and surgery are local treatments the medical treatment pursues the elimination of all the body’s tumour cells. This last one consists in the administration of medications to treat tumours. It can be used as a single treatment or in conjunction with surgery and/or radiotherapy and/or biological treatments. Depending on the type and the state of the illness, the medical treatment can be used to cure the tumour, impede it from spreading, delay its growth or reduce (improve) the symptoms that it may produce.

Can cancer be cured?

In half of the cases cancer can be cured, especially in the initial stages, stages I-II, that is why early detection is important. There are tumours which even in advanced stages of metastasis are possible to cure, like lymphomas or testicle cancer. 

We use cookies to enhance the browsing experience. By continuing navigation we understand you accept our cookie policyclose